Clinical Trial Update: Comparing Treatment of Dry Eye With Intracanalicular Dexamethasone, Restasis, and/or Lotemax [Phase 4]

View source ↗

Summary

Phase 4 trial update comparing intracanalicular dexamethasone with Restasis and/or Lotemax for dry eye has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye

Drugs mentioned

• Lotemax (Loteprednol etabonate)
• Restasis (Cyclosporine A)
• dexamethasone intracanalicular (dexamethasone)

Snippet

Sponsor: Thomas Chester, OD | Conditions: Dry Eye | Phase 4 | Status: COMPLETED | Results posted: 2023-10-11